Noveris Health Sciences Inc. Registered Shares o.N.
- BID
0.765
- ASK
0.81
- 2,000 Units2,000 Units
- 07/22, 09:33:13 AM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
515.00%
Market Cap
-
P/E Ratio
0.13
Dividend Yield
0.00 %
Earnings per Share
1.50 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.765 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 09:33:13 AM | |
| DAILY VOLUME (UNITS) | 10,000 | |
| DAILY HIGH / LOW | 0.85 | 0.75 |
| PREV. DAY'S PRICE | 0.71 | (07/21) |
| CHANGE DAY BEFORE | +0.06 | 7.75 % |
| 52 WEEK HIGH / LOW | 1.81 (06/09) | 0.05 (02/13) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -23.39 | -1.78 | 1.50 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | 0.13 | - | - |
PRICE - BOOK RATIO | - | - | - | - | - |
PRICE - SALES RATIO | - | - | - | - | - |
PRICE - CASH FLOW RATIO | - | - | 40.73 | - | - |
Master Data
| WKN | A42208 |
| ISIN | CA66990B1085 |
| SYMBOL | 0NF1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | NOVERIS HEALTH SCI. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -41.43 % | -40.29 % | - | 284.38 % | 515.00 % | -90.47 % | -99.91 % | 344.04 % |
| HIGH | 1.06 | 1.19 | 1.81 | 1.81 | 1.81 | 7.55 | 851.25 | 1.81 |
| LOW | 0.61 | 0.61 | 0.54 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Dividende
pro Aktie
NOVERIS HEALTH SCI. does not deliver dividend information
Company profile
Noveris Health Sciences, Inc. is a biotechnology company, which engages in the development of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD). The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.